You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

November 4, 2019

Patent Filing Statistics in the Pharmaceutical Sector in Vietnam

With the growth of Vietnam’s economy and population, the country’s pharmaceutical market has become increasingly important. Vietnam is classified by the IQVIA Institute as a “pharmerging” market—a developing country with a relatively low per capita income but strong market growth potential for prescription medication. According to statistics from the Drug Administration of Vietnam (DAV), the sector will continue to see double-digit growth for the next five years, offering many opportunities for development.

The statistics presented in this report on pharmaceutical patent filings in Vietnam reveal some trends, challenges, and opportunities in this important market.

Please click the link below to view the entire report.

RELATED INSIGHTS​ 

March 19, 2020
The effects of the global COVID-19 pandemic on Southeast Asia are a deep concern shared by all with connections to the region. To encourage clear understanding of the facts on the ground, Tilleke & Gibbins has prepared this high-level snapshot of the legal situation as it currently stands in each of our jurisdictions.Administrative and Judicial Functions
March 18, 2020
On February 24, 2020, the government of Vietnam issued Decree No. 24/2020/ND-CP (“Decree 24”) providing detailed guidance on the 2019 Law on Prevention and Control of Harmful Effects of Alcoholic Beverages (the “Law on Alcoholic Beverages”), which took effect on January 1, 2020. Among other things, Decree 24 provides further guidance about the restrictions on consumption, advertising, and trading of alcoholic beverages. Below is a summary of these provisions:Consumption of alcoholic beverages
March 2, 2020
Non-communicable diseases (NCDs) mainly consist of cardiovascular diseases, cancers, chronic respiratory diseases, and diabetes, and are the most frequent causes of death worldwide. A 2018 World Health Organization (WHO) fact sheet on NCDs notes that 41 million people die annually from NCDs (71% of global deaths), including 15 million people who die before the age of 70.